Bausch Health Companies Inc. - Common Shares, No Par Value (BHC)

Historical Holders from Q2 2015 to Q3 2025

Symbol
BHC on NYSE
Type / Class
Equity / Common Shares, No Par Value
Shares outstanding
374M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
241M
Holdings value
$1.55B
% of all portfolios
0.005%
Grand Portfolio weight change
0%
Number of holders
214
Number of buys
91
Number of sells
-89
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Bausch Health Companies Inc. - Common Shares, No Par Value (BHC)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PAULSON & CO. INC. 19.1% +113% $468M $251M 70.8M +116% PAULSON & CO. INC. 14 Aug 2025
MERUELO ALEX 9.99% $199M 36.8M Alex Meruelo 31 Mar 2025
GOLDENTREE ASSET MANAGEMENT LP 9.5% $233M 35.2M Steven A. Tananbaum 30 Jun 2025
NOMURA HOLDINGS INC 4.2% -35% $101M -$49.6M 15.7M -32.9% NOMURA HOLDINGS INC 30 Sep 2025

Institutional Holders of Bausch Health Companies Inc. - Common Shares, No Par Value (BHC)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 241M $1.55B -$30.4M $6.45 214
2025 Q2 246M $1.64B +$16.9M $6.66 207
2025 Q1 244M $1.58B -$74.5M $6.47 224
2024 Q4 246M $1.98B -$21.3M $8.06 218
2024 Q3 255M $2.08B -$179M $8.16 205
2024 Q2 280M $1.95B -$48.8M $6.97 224
2024 Q1 267M $2.83B -$6.7M $10.61 222
2023 Q4 286M $2.29B +$23.8M $8.02 227
2023 Q3 282M $2.33B +$141M $8.22 217
2023 Q2 265M $2.12B -$46.1M $8.00 226
2023 Q1 278M $2.25B -$139M $8.10 230
2022 Q4 280M $1.76B +$234M $6.28 246
2022 Q3 242M $1.67B -$25.1M $6.89 258
2022 Q2 241M $2.02B -$558M $8.36 294
2022 Q1 256M $5.85B -$158M $22.85 351
2021 Q4 260M $7.18B +$49.4M $27.61 359
2021 Q3 253M $7.07B +$43.4M $27.85 327
2021 Q2 252M $7.4B +$247M $29.32 343
2021 Q1 238M $7.55B +$510M $31.74 333
2020 Q4 231M $4.82B +$197M $20.80 315
2020 Q3 224M $3.48B -$62.7M $15.54 303
2020 Q2 231M $4.23B -$199M $18.29 290
2020 Q1 241M $3.73B +$237M $15.50 290
2019 Q4 221M $6.65B +$531M $29.92 313
2019 Q3 205M $4.47B +$98M $21.85 303
2019 Q2 198M $5B +$238M $25.22 316
2019 Q1 190M $4.68B +$34.5M $24.70 327
2018 Q4 190M $3.51B +$216M $18.47 308
2018 Q3 176M $4.54B +$4.37B $25.67 306
2018 Q2 6.45M $150M +$150M $23.24 18
2016 Q2 0 $0 -$529K 0
2016 Q1 21.4K $529K $24.72 1
2015 Q3 0 $0 -$337K 0
2015 Q2 1.52K $337K +$337K $221.71 1